Edition:
United Kingdom

Vcanbio Cell & Gene Engineering Corp Ltd (600645.SS)

600645.SS on Shanghai Stock Exchange

15.49CNY
19 Oct 2018
Change (% chg)

¥0.50 (+3.34%)
Prev Close
¥14.99
Open
¥14.60
Day's High
¥15.65
Day's Low
¥14.52
Volume
6,695,325
Avg. Vol
9,018,627
52-wk High
¥27.58
52-wk Low
¥14.52

Latest Key Developments (Source: Significant Developments)

Zhongyuan Union Cell & Gene Engineering Gets Regulatory Approval For Asset Acquisition
Wednesday, 1 Aug 2018 

Aug 1 (Reuters) - Zhongyuan Union Cell & Gene Engineering Corp Ltd <600645.SS>::SAYS IT GETS SECURITIES REGULATOR'S APPROVAL FOR ASSET ACQUISITION.  Full Article

Zhongyuan Union Cell & Gene Gets Approval For Asset Acquisition, Trading In Shares To Resume
Wednesday, 6 Jun 2018 

June 6 (Reuters) - Zhongyuan Union Cell & Gene Engineering Corp Ltd <600645.SS>::SAYS IT GETS REGULATORY APPROVAL FOR ASSET ACQUISITION, TRADING IN SHARES TO RESUME ON JUNE 7.  Full Article

Zhongyuan Union Cell Receives CFIUS Notice Regarding Its Plan To Indirectly Acquire Origene Technologies Inc
Monday, 23 Apr 2018 

April 23 (Reuters) - Zhongyuan Union Cell & Gene Engineering Corp Ltd <600645.SS>::SAYS IT RECEIVES NOTICE FROM U.S. CFIUS THAT IT HAS COMPLETED THE REVIEW OF COMPANY'S ACQUISITION PROPOSAL TO INDIRECTLY ACQUIRE ORIGENE TECHNOLOGIES INC.  Full Article

Zhongyuan Union Cell & Gene Engineering says individual to add stake in co within 6 months
Friday, 2 Feb 2018 

Feb 2 (Reuters) - Zhongyuan Union Cell & Gene Engineering Corp Ltd <600645.SS> ::Says an individual Gong Hongjia plans to add at least 3 percent or no more than 5 percent stake of shares of the company within 6 months since Feb. 2.  Full Article

Zhongyuan Union Cell & Gene Engineering To Buy Shanghai Firm for 1.2 Bln Yuan
Thursday, 4 Jan 2018 

Jan 4 (Reuters) - Zhongyuan Union Cell & Gene Engineering Corp Ltd <600645.SS>::SAYS TO BUY SHANGHAI-BASED MEDICAL EQUIPMENT FIRM FOR 1.2 BILLION YUAN ($184.79 million) VIA SHARE ISSUE.SAYS IT AIMS TO RAISE UP TO 500 MILLION YUAN IN PRIVATE PLACEMENT OF SHARES TO FUND PROJECTS.  Full Article

Zhongyuan Union Cell & Gene Engineering unit liquidates Tianjin-based hospital management firm
Thursday, 30 Nov 2017 

Nov 30 (Reuters) - Zhongyuan Union Cell & Gene Engineering Co Ltd <600645.SS>:Says its unit liquidated Tianjin-based hospital management firm .  Full Article

Zhongyuan Union Cell & Gene Engineering to sell stake in pharmaceutical tech firm for 60 mln yuan
Monday, 27 Nov 2017 

Nov 27 (Reuters) - Zhongyuan Union Cell & Gene Engineering Co Ltd <600645.SS> ::Says it plans to sell 67 percent stake in a Zhejiang-based pharmaceutical tech firm, for 60 million yuan .  Full Article

Zhongyuan Union Cell & Gene Engineering in deal to buy medical supplies firm
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Zhongyuan Union Cell & Gene Engineering Co Ltd <600645.SS> ::Says it is in deal to buy a Shanghai-based medical supplies firm, with further details to be determined .  Full Article

Zhongyuan Union Cell & Gene Engineering announces change in accounting policy
Wednesday, 1 Nov 2017 

Nov 1(Reuters) - Zhongyuan Union Cell & Gene Engineering Corp Ltd <600645.SS>:Says it changes accounting policy based on accounting standards for business enterprises No. 16—government subsidies, which was disclosed by the Ministry of Finance on May 10, effective June 12.  Full Article

Zhongyuan Union Cell & Gene Engineering Corp says resignation of CFO
Monday, 24 Jul 2017 

July 24 (Reuters) - Zhongyuan Union Cell & Gene Engineering Corp Ltd <600645.SS> ::* Says Han Yue'e resigned from CFO of the company.  Full Article

Shanghai stocks post 3rd weekly fall on concerns over 'unicorns' listings

* Gains in Shanghai stocks led by Youon Technology Co Ltd and losses by Henan Yinge Industrial Investment Co Ltd